Monday, May 21, 2018 7:49:06 PM
https://www.markets.co/h-c-wainwright-thinks-nabrivas-stock-is-going-to-recover/158743/
In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Nabriva (NASDAQ: NBRV), with a price target of $20. The company’s shares opened today at $6, close to its 52-week low of $4.39.
According to TipRanks.com, Arce is a 5-star analyst with an average return of 21.9% and a 44.7% success rate. Arce covers the Healthcare sector, focusing on stocks such as Collegium Pharmaceutical, Conatus Pharmaceuticals, and Aurinia Pharmaceuticals.
Currently, the analyst consensus on Nabriva is Strong Buy and the average price target is $14.67, representing a 144.5% upside.
In a report issued on May 8, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $16 price target.
See today’s analyst top recommended stocks >>
Based on Nabriva’s latest earnings release for the quarter ending December 31, the company reported a quarterly GAAP net loss of $22.26 million. In comparison, last year the company had a GAAP net loss of $15.22 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Nabriva Therapeutics Plc is a clinical stage biopharmaceutical company, which engages in the research and development of novel antibiotics to treat serious infections. Its lead product candidate, lefamulin, is a pleuromutilin antibiotic available for systemic administration in humans.
Recent NBRVF News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:08:06 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM